Your browser doesn't support javascript.
loading
From ICI to ICU: Ipilimumab and Nivolumab-Induced Immune Checkpoint Inhibitor Colitis.
Zhou, Wendy; Frye, Joseph; Soroudi, Camille; Triadafilopoulos, George; Berry, Rani.
Afiliação
  • Zhou W; Department of Medicine, Santa Clara Valley Medical Center, San Jose, CA, USA. wendyzhou16@gmail.com.
  • Frye J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Soroudi C; Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, CA, USA.
  • Triadafilopoulos G; Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
  • Berry R; Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Dig Dis Sci ; 67(3): 800-803, 2022 03.
Article em En | MEDLINE | ID: mdl-34159488
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Nivolumabe Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Nivolumabe Idioma: En Ano de publicação: 2022 Tipo de documento: Article